Baylor University Medical Center
Dallas, Texas, 75246, United States
NCT Number: NCT02070315
Liver biopsy for the assessment of fibrosis has multiple limitations. Liver ShearWaveTM Elastography may provide a non-invasive, fast, and reproducible alternative for the quantitative assessment of liver fibrosis.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Dallas, Texas, 75246, United States
To obtain a quantitative evaluation of the progression of liver disease, using ShearWaveTM Elastography measurements obtained with the Supersonic Imagine Aixplorer ultrasound machine.
To compare the glomerular filtration rate and the quantitative evaluation of the progression of renal disease, using ShearWaveTM Elastography measurements obtained with the Supersonic Imagine Aixplorer ultrasound machine in post-liver transplantation patients.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 1 day
Patients will have a scan performed at their regularly scheduled clinic visits.
Baylor Research Institute
Other
Quantitative Evaluation of Liver Disease With Liver and Kidney Elastography Using the Supersonic Imagine Aixplorer ShearWaveTM Elastography Ultrasound Machine
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04116242
Acute-On-Chronic Liver Failure, Cirrhosis of the Liver
Basel, Switzerland
View Trial DetailsNCT01081210
Aortic Disease, Aortic Diseases
Levanger, Norway
View Trial DetailsNCT01331187
Aortic Disease, Aortic Diseases
Levanger, Norway
View Trial DetailsNCT02520609
Digestive System Diseases, Fatty Liver
Bethesda, Maryland, United States
View Trial Details